Vision care company Positive Impact has recently announced it is to be UK distributor for the BVI range of Parasol and Extend punctal plugs, adding to its acquisition of InflammaDry. To complement these products, a series of regional seminars recently took place, culminating in an evening in London.
The session started with a CET lecture from Positive Impact joint managing director and optician Nick Atkins looking at the latest dry eye diagnostic techniques, as well as where punctal occlusion fits into the current patient management options.
One of the key messages was that, in its 2007 report, the Dry Eye Workshop (Dews) elevated ‘plugging’ to a severity level 2 management strategy. Atkins observed that he, like many practitioners, once assumed that plugs were a last resort. However, Dews puts plugging alongside anti-inflammatory agents, such as omega 3, as a second stage option when eye drops aren’t completely effective.
Register now to continue reading
Thank you for visiting Optician Online. Register now to access up to 10 news and opinion articles a month.
Register
Already have an account? Sign in here